Literature DB >> 12202940

Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra.

Markku Multanen1, Teuvo L J Tammela, Marita Laurila, Jukka Seppälä, Tero Välimaa, Pertti Törmälä, Martti Talja.   

Abstract

The purpose of this study was to evaluate the biocompatibility, encrustation and biodegradation properties of silver nitrate and ofloxacine blended caprolactone-L-lactide copolymer coated self-reinforced poly-L-lactic acid (SR-PLLA) urospirals in situ in the male rabbit urethra. SR-PLLA urospirals coated with 10% by weight silver nitrate or 5% by weight ofloxacine blended copolymer or pure copolymer were inserted into the posterior urethra of 18 male rabbits. No prophylactic antibiotics were given. The animals were sacrificed 1 or 6 months after insertion. Urethral tissue reactions were histologically scored semiquantitavely and the appearence of the stents assessed using scanning electron microscopy. The biodegradation time of SR-PLLA stents was remarkably reduced by the caprolactone coating. Silver nitrate and ofloxacine blended copolymer coated urospirals caused less tissue reaction than urospirals with a pure copolymer coating. Silver nitrate coating effectively prevented biofilm formation and stent encrustation. Silver nitrate and ofloxacine blended copolymer coated SR-PLLA urospirals had good biocompatibility properties in rabbit urethra. In particular, coating with silver nitrate may provide possibilities of preventing bacterial adhesion to bioabsorbable stents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202940     DOI: 10.1007/s00240-002-0252-7

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  7 in total

1.  In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - drug release, polymer degradation and mechanical integrity.

Authors:  Katrin Sternberg; Sven Kramer; Claudia Nischan; Niels Grabow; Thomas Langer; Gerhard Hennighausen; Klaus-Peter Schmitz
Journal:  J Mater Sci Mater Med       Date:  2007-03-27       Impact factor: 3.896

2.  Comparison of safety and efficacy of silodosin, solifenacin, tadalafil and their combinations in the treatment of double-J stent- related lower urinary system symptoms: A prospective randomized trial.

Authors:  Rohit Bhattar; Vinay Tomar; Sher Singh Yadav; Devendra Singh Dhakad
Journal:  Turk J Urol       Date:  2018-03-06

3.  Effect of uropathogens on in vitro encrustation of polyurethane double J ureteral stents.

Authors:  Nandakumar Venkatesan; Sunil Shroff; Karthik Jeyachandran; Mukesh Doble
Journal:  Urol Res       Date:  2010-06-02

4.  A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms.

Authors:  Satinder Pal Aggarwal; Shivam Priyadarshi; Vinay Tomar; S S Yadav; Goto Gangkak; Nachiket Vyas; Neeraj Agarwal; Ujwal Kumar
Journal:  Adv Urol       Date:  2015-12-14

5.  Ureteral stent discomfort: Etiology and management.

Authors:  Ricardo Miyaoka; Manoj Monga
Journal:  Indian J Urol       Date:  2009 Oct-Dec

6.  Physical Properties of Electropolished CoCrMo Alloy Coated with Biodegradable Polymeric Coatings Releasing Heparin after Prolonged Exposure to Artificial Urine.

Authors:  Wojciech Kajzer; Janusz Szewczenko; Anita Kajzer; Marcin Basiaga; Joanna Jaworska; Katarzyna Jelonek; Katarzyna Nowińska; Marcin Kaczmarek; Ada Orłowska
Journal:  Materials (Basel)       Date:  2021-05-14       Impact factor: 3.623

Review 7.  Biomaterials in urology.

Authors:  Darren T Beiko; Bodo E Knudsen; James D Watterson; John D Denstedt
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.